• Je něco špatně v tomto záznamu ?

The role of the qacA gene in mediating resistance to quaternary ammonium compounds

D. Cervinkova, V. Babak, D. Marosevic, I. Kubikova, Z. Jaglic,

. 2013 ; 19 (3) : 160-7.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14040964
E-zdroje Online Plný text

NLK ProQuest Central od 2000-06-01 do 2018-12-31
Health & Medicine (ProQuest) od 2000-06-01 do 2018-12-31
Public Health Database (ProQuest) od 2000-06-01 do 2018-12-31

Conditions facilitating resistance to quaternary ammonium compounds (QACs) were investigated in Staphylococcus aureus SK982 exposed to benzalkonium chloride (BAC; a member of QACs) under various circumstances. S. aureus SK982 carrying the qacA gene encoding for resistance to QACs was grown in the presence of stable or gradually increasing concentrations of BAC, or it was exposed to this antiseptic in the exponential phase of growth. Bacteria cultivated in the highest BAC concentrations that did not retard their growth comparing to the untreated control were subjected to real-time quantitative polymerase chain reaction analysis for relative expression of the efflux genes qacA and norA. Under such conditions, S. aureus SK982 tolerated a relatively low stable concentration of BAC (1.22 mg/L) when compared with a gradually increasing antiseptic concentration (tolerance of 4.88 mg/L). However, in both cases, qacA expression was not significant. The culture exposed in the exponential phase of growth tolerated the highest concentration of BAC (9.76 mg/L) as also accompanied by significant overexpression of qacA. Expression of norA was relatively low regardless of the conditions tested. It seems that under the short-term conditions, the phase of bacterial growth is more important for the expression of BAC resistance than the capability to adapt to this antiseptic. This study provides a deeper insight into the relevance of the qac genes in conferring resistance to QACs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14040964
003      
CZ-PrNML
005      
20140114101925.0
007      
ta
008      
140107s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1089/mdr.2012.0154 $2 doi
035    __
$a (PubMed)23256651
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Cervinkova, Dana
245    14
$a The role of the qacA gene in mediating resistance to quaternary ammonium compounds / $c D. Cervinkova, V. Babak, D. Marosevic, I. Kubikova, Z. Jaglic,
520    9_
$a Conditions facilitating resistance to quaternary ammonium compounds (QACs) were investigated in Staphylococcus aureus SK982 exposed to benzalkonium chloride (BAC; a member of QACs) under various circumstances. S. aureus SK982 carrying the qacA gene encoding for resistance to QACs was grown in the presence of stable or gradually increasing concentrations of BAC, or it was exposed to this antiseptic in the exponential phase of growth. Bacteria cultivated in the highest BAC concentrations that did not retard their growth comparing to the untreated control were subjected to real-time quantitative polymerase chain reaction analysis for relative expression of the efflux genes qacA and norA. Under such conditions, S. aureus SK982 tolerated a relatively low stable concentration of BAC (1.22 mg/L) when compared with a gradually increasing antiseptic concentration (tolerance of 4.88 mg/L). However, in both cases, qacA expression was not significant. The culture exposed in the exponential phase of growth tolerated the highest concentration of BAC (9.76 mg/L) as also accompanied by significant overexpression of qacA. Expression of norA was relatively low regardless of the conditions tested. It seems that under the short-term conditions, the phase of bacterial growth is more important for the expression of BAC resistance than the capability to adapt to this antiseptic. This study provides a deeper insight into the relevance of the qac genes in conferring resistance to QACs.
650    _2
$a antibakteriální látky $x aplikace a dávkování $x farmakologie $7 D000900
650    _2
$a bakteriální proteiny $x genetika $7 D001426
650    _2
$a benzalkoniové sloučeniny $x aplikace a dávkování $x farmakologie $7 D001548
650    _2
$a bakteriální léková rezistence $x genetika $7 D024881
650    _2
$a regulace genové exprese u bakterií $7 D015964
650    _2
$a membránové transportní proteiny $x genetika $7 D026901
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a proteiny spojené s mnohočetnou rezistencí k lékům $x genetika $7 D027425
650    _2
$a kvantitativní polymerázová řetězová reakce $7 D060888
650    _2
$a Staphylococcus aureus $x účinky léků $x genetika $7 D013211
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Babak, Vladimir $u -
700    1_
$a Marosevic, Durdica $u -
700    1_
$a Kubikova, Iva $u -
700    1_
$a Jaglic, Zoran $u -
773    0_
$w MED00008749 $t Microbial drug resistance (Larchmont, N.Y.) $x 1931-8448 $g Roč. 19, č. 3 (2013), s. 160-7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23256651 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140107 $b ABA008
991    __
$a 20140114102629 $b ABA008
999    __
$a ok $b bmc $g 1005360 $s 839476
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 19 $c 3 $d 160-7 $i 1931-8448 $m Microbial drug resistance $n Microb Drug Resist $x MED00008749
LZP    __
$a Pubmed-20140107

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...